Seaweed called hijiki should not be eaten due to high levels of arsenic

NewsGuard 100/100 Score

The Food Standards Agency is advising people not to eat a type of seaweed called hijiki because of the high levels of arsenic that it contains.

A survey carried out by the Agency found that hijiki contains inorganic arsenic, a form that occurs naturally in some food and can increase people's risk of developing cancer if eaten regularly.

Hijiki is a distinctive, almost black, shredded seaweed, that is used mainly as an appetiser or starter in some Japanese restaurants. It is not used in sushi or in Chinese restaurants. If you have eaten hijiki occasionally it is unlikely that you have raised your risk of developing cancer significantly.

Hijiki is also sold for use in soups and salads and some vegetarian and vegan dishes where seaweed is an ingredient. It is sometimes found in the specialist food sections of some supermarkets and department stores and in health food shops and specialist shops selling Asian and Far Eastern food.

The Agency carried out a survey of five different types of seaweed following reports from Canada that there was a problem with hijiki. They also tested arame, kombu, nori and wakame and didn't find inorganic arsenic in these types of seaweed.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Triple-negative breast cancer patients with high immune cell levels have lower relapse risk after surgery